Korey K Hood1, Esti Iturralde2, Joseph Rausch3, Jill Weissberg-Benchell4. 1. Department of Pediatrics, Stanford University School of Medicine, Stanford, CA kkhood@stanford.edu. 2. Department of Pediatrics, Stanford University School of Medicine, Stanford, CA. 3. The Research Institute at Nationwide Children's Hospital, Department of Pediatrics, The Ohio State University, Columbus, OH. 4. Department of Psychiatry and Behavioral Sciences, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University's Feinberg School of Medicine, Chicago, IL.
Abstract
OBJECTIVE: The aim is to report 1-year outcomes of the Supporting Teens Problem Solving (STePS) study, a randomized controlled trial comparing a distress and depression prevention program with a diabetes education program for adolescents with type 1 diabetes. RESEARCH DESIGN AND METHODS: With 264 adolescents in two locations (Chicago and San Francisco Bay Area), a randomized controlled trial was conducted comparing the Penn Resilience Program for type 1 diabetes (PRP T1D) to Advanced Diabetes Education. Interventions lasted 4.5 months, and assessments were conducted at baseline, and 4.5, 8, 12, and 16 months. Outcomes of interest were diabetes distress (DD), depressive symptoms, resilience, diabetes self-management, and glycemic control. Latent growth curve modeling was used to test between-group differences over time. RESULTS: Results indicate that there was acceptable randomization and exposure to interventions, and that exposure to PRP T1D was associated with substantial reductions in DD. In addition, stable glycemic control, resilience characteristics, and depressive symptoms were observed 1 year post-treatment. Diabetes management deteriorated in both groups. CONCLUSIONS: Intervening before symptoms of psychological distress start can prevent the development of the DD commonly seen in adolescents with type 1 diabetes. The STePS program represents a promising prevention program, and future reports on 2- and 3-year outcomes will explore benefits over longer periods of time.
RCT Entities:
OBJECTIVE: The aim is to report 1-year outcomes of the Supporting Teens Problem Solving (STePS) study, a randomized controlled trial comparing a distress and depression prevention program with a diabetes education program for adolescents with type 1 diabetes. RESEARCH DESIGN AND METHODS: With 264 adolescents in two locations (Chicago and San Francisco Bay Area), a randomized controlled trial was conducted comparing the Penn Resilience Program for type 1 diabetes (PRP T1D) to Advanced Diabetes Education. Interventions lasted 4.5 months, and assessments were conducted at baseline, and 4.5, 8, 12, and 16 months. Outcomes of interest were diabetes distress (DD), depressive symptoms, resilience, diabetes self-management, and glycemic control. Latent growth curve modeling was used to test between-group differences over time. RESULTS: Results indicate that there was acceptable randomization and exposure to interventions, and that exposure to PRP T1D was associated with substantial reductions in DD. In addition, stable glycemic control, resilience characteristics, and depressive symptoms were observed 1 year post-treatment. Diabetes management deteriorated in both groups. CONCLUSIONS: Intervening before symptoms of psychological distress start can prevent the development of the DD commonly seen in adolescents with type 1 diabetes. The STePS program represents a promising prevention program, and future reports on 2- and 3-year outcomes will explore benefits over longer periods of time.
Authors: Kellee M Miller; Nicole C Foster; Roy W Beck; Richard M Bergenstal; Stephanie N DuBose; Linda A DiMeglio; David M Maahs; William V Tamborlane Journal: Diabetes Care Date: 2015-06 Impact factor: 19.112
Authors: Korey K Hood; Daniel P Beavers; Joyce Yi-Frazier; Ronny Bell; Dana Dabelea; Robert E Mckeown; Jean M Lawrence Journal: J Adolesc Health Date: 2014-05-10 Impact factor: 5.012
Authors: A Nicolucci; K Kovacs Burns; R I G Holt; M Comaschi; N Hermanns; H Ishii; A Kokoszka; F Pouwer; S E Skovlund; H Stuckey; I Tarkun; M Vallis; J Wens; M Peyrot Journal: Diabet Med Date: 2013-07 Impact factor: 4.359
Authors: J J Wong; A Addala; D Naranjo; K K Hood; E Cengiz; M K Ginley; R S Feinn; J A Wagner Journal: Diabet Med Date: 2019-11-19 Impact factor: 4.359
Authors: Marisa E Hilliard; Viena T Cao; Sahar S Eshtehardi; Charles G Minard; Rana Saber; Debbe Thompson; Lefkothea P Karaviti; Barbara J Anderson Journal: Diabetes Technol Ther Date: 2020-05-22 Impact factor: 6.118
Authors: Korey K Hood; Lori M Laffel; Thomas Danne; Revital Nimri; Stuart A Weinzimer; Judy Sibayan; Ryan J Bailey; Desmond Schatz; Natasa Bratina; Rachel Bello; Alina Punel; Peter Calhoun; Roy W Beck; Richard M Bergenstal; Moshe Phillip Journal: Diabetes Technol Ther Date: 2021-10-26 Impact factor: 6.118
Authors: Anthony T Vesco; Kelsey R Howard; Lindsay M Anderson; Jaclyn L Papadakis; Korey K Hood; Jill Weissberg-Benchell Journal: Can J Diabetes Date: 2021-05-11 Impact factor: 2.774